$4.60
-0.40[-8.00%]
At close: Apr 22
$4.60
0[0.00%]
PreMarket: 6:14PM EDT
Vaccinex
(NASDAQ:VCNX)Latest News for Vaccinex Stock (NASDAQ:VCNX)
Vaccinex Stock (NASDAQ: VCNX)
Categories: All
Tuesday, April 02, 2024
- Vaccinex Q4 EPS $(0.33) Up From $(23.10) YoYBenzinga Newsdesk - Apr 2, 2024, 10:59PM
- Vaccinex Expects Topline Data For Phase 1/2a Randomized SIGNAL-AD Study Of Pepinemab For Alzheimer's Disease In Q3 2024Benzinga Newsdesk - Apr 2, 2024, 8:45AM
- Vaccinex FY23 EPS $(43.68) Up From $(98.05) YoY, Revenue $570K Up From $275K YoYBenzinga Newsdesk - Apr 2, 2024, 8:44AM
Wednesday, March 27, 2024
Wednesday, February 21, 2024
Tuesday, February 20, 2024
Friday, February 16, 2024
Thursday, February 15, 2024
Wednesday, February 14, 2024
Friday, February 09, 2024
Wednesday, February 07, 2024
Monday, December 04, 2023
Monday, November 13, 2023
Tuesday, October 31, 2023
Thursday, October 26, 2023
Friday, October 13, 2023
Wednesday, October 11, 2023
Monday, October 09, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Oct 9, 2023, 5:31PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Oct 9, 2023, 1:31PM
- Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Oct 9, 2023, 1:30PM
Friday, October 06, 2023
- Gold Moves Higher; OMNIQ Shares PlungeLisa Levin - Oct 6, 2023, 2:31PM
- Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Oct 6, 2023, 1:59PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Oct 6, 2023, 1:31PM
- Vaccinex shares are trading higher after two insider buys were reported after the close on Thursday.Bill Haddad - Oct 6, 2023, 11:19AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Oct 6, 2023, 9:06AM
- Market-Moving News for October 6thBenzinga Newsdesk - Oct 6, 2023, 8:39AM
- Why Pioneer Natural Resources Shares Are Bouncing By Around 12%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 6, 2023, 8:26AM
- Vaccinex Shares Up 43% Premarket. Two Large Insider Buys Were Reported After The Close On ThursdayCharles Gross - Oct 6, 2023, 4:39AM
Thursday, October 05, 2023
Friday, September 29, 2023
- Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Sep 29, 2023, 2:09PM
- Stocks That Hit 52-Week Lows On FridayBenzinga Insights - Sep 29, 2023, 2:09PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Sep 29, 2023, 1:31PM
- Vaccinex shares are trading lower after the company announced the pricing of a $9.6 million public offering of 9.6 million shares and warrants at $1 per share.Benzinga Newsdesk - Sep 29, 2023, 10:39AM
- Nasdaq Gains Over 1%; Nike Posts Upbeat EarningsLisa Levin - Sep 29, 2023, 10:16AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Sep 29, 2023, 9:05AM
- Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 29, 2023, 8:15AM
- Vaccinex Prices $9.6M Public Offering Of 9.6M Common Shares And Warrants At $1/ShareBenzinga Newsdesk - Sep 29, 2023, 3:07AM
Thursday, September 28, 2023
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Sep 28, 2023, 2:32PM
- Vaccinex shares are trading higher after the company announced its next generation ActivMAb technology was published in mAbs and validated in an OmniAb proof-of-concept collaboration.Benzinga Newsdesk - Sep 28, 2023, 11:27AM
- Vaccinex's Next Generation ActivMAb Technology Published In mAbs, A Leading Biotech Journal, And Validated In OmniAb Proof-Of-Concept CollaborationBenzinga Newsdesk - Sep 28, 2023, 8:10AM
Tuesday, September 26, 2023
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Sep 26, 2023, 12:04PM
- Vaccinex Recent Insider ActivityBenzinga Insights - Sep 26, 2023, 11:03AM
- Vaccinex Reports Groundbreaking Findings At Medical Conferences Supporting Development Of Pepinemab For The Treatment Of Neurodegenerative Diseases And CancerBenzinga Newsdesk - Sep 26, 2023, 8:14AM